New Survey Reveals 73% of Pharmacists Say Amoxicillin Shortage Continues
Drug pricing regulator National Pharmaceutical Pricing Authority has revised prices of 128 drugs, including antibiotics and antiviral medications. The formulations for which the ceiling price has been fixed include antibiotic injections of Amoxicillin and Clavulanic acid; Vancomycin, asthma medication Salbutamol, cancer drug Trastuzumab, brain tumour treatment drug Temozolomide, painkiller Ibuprofen and paracetamol which is used to treat pain and fever.
TORONTO--(BUSINESS WIRE)--Juno Pharmaceuticals Canada (“Juno”), a Canadian specialty pharmaceutical company, announced that it has received approval from Health Canada to import Amoxicillin powder for oral suspension (“Amoxicillin”) pursuant to Health Canada’s exceptional importation and sale guidelines. This approval will help relieve the current nationwide shortage of a critical antibiotic product and most importantly, allow it to reach pediatric and geriatric patients alike. Through this initiative with both its vendor partners and importation approval from Health Canada, Juno has procured close to 100,000 bottles. Delivery of the first order is underway with the remaining orders expected throughout January. The product will be distributed to hospitals, pharmacies and retail wholesalers in every province and territory.
Australia’s Therapeutic Goods Administration (TGA) is allowing pharmacists to dispense amoxicillin in different dosage forms that those stated on the prescription to mitigate shortages of liquid, tablet and capsule formulations of the antibiotic.
STATEN ISLAND, N.Y. — Some commonly used medications are in short supply due to supply chain issues, according to the U.S. Food and Drug Administration (FDA). Here are the four most common drugs that are becoming increasingly more difficult to obtain and what you can do if you are affected by the growing shortage.
With the US staring down several drug shortages this year, one in particular is now catching lawmakers’ attention.
BRISTOL, Tenn., Nov. 7, 2022 /PRNewswire/ -- Today, USAntibiotics, the sole licensed American manufacturer of penicillin-based Amoxicillin and Amoxil Clavulanate, the popular antibiotics commonly known as Amoxil® and Augmentin®, released the following statement from Patrick Cashman, President of USAntibiotics, regarding reported shortages of this life-saving drug:
Three of the top four makers of the antibiotic amoxicillin, commonly used to treat bacterial infections in children, are reporting supply constraints in the US.
SOMERSET, N.J., June 9, 2022 /PRNewswire-PRWeb/ -- Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today welcomed the recent announcement by Phathom Pharmaceuticals that the U.S. Food and Drug Administration (FDA) has approved both VOQUEZNA™ TRIPLE PAK™ (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA™ DUAL PAK™ (vonoprazan tablets, amoxicillin capsules), for the treatment of Helicobacter pylori (H. pylori) infection in adults. These new treatment options contain antibiotics conveniently packaged with vonoprazan, a novel potassium-competitive acid blocker (PCAB) and the first innovative acid suppressant from a new drug class approved in the U.S. in over 30 years. For more information on the VOQUEZNA treatment regimens, including important safety information.
New Jersey-based pharmaceutical company, Phathom Pharmaceuticals (NASDAQ:PHAT), announced that the U.S. Food and Drug Administration (FDA) approved its antibacterial drugs, Voquezna Triple Pak and Voquezna Dual Pak, for the treatment of Helicobacter pylori infection in adults.